<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a major risk factor for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>It is important to decide when and how to treat the patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="2" pm="."><plain>It was reported that HDAC-1 (<z:chebi fb="0" ids="15358">Histone</z:chebi> Deacetylase-1) and MTA-1 (<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e>-Associated Protein-1) were associated with initiation and progression of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study is to assess malignant potential of BE using the expression of HDAC-1 and MTA-1 </plain></SENT>
<SENT sid="4" pm="."><plain>METHODOLOGY: Seven BE cases with pathological specialized columnar epithelium and CK7/20 in an immunohistochemically positive state were selected from resected specimens of 23 patients with gastro-esophageal junction <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The expression of HDAC-1 and MTA-1 protein was evaluated using an immunohistochemical method </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> seven cases with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> were diagnosed as low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Positive expression of HDAC-1 and MTA-1 was found in 0 out of 7 cases (0%) with <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelium, and 0 out of 7 cases (0%) with <z:mpath ids='MPATH_458'>normal</z:mpath> gastric epithelium </plain></SENT>
<SENT sid="8" pm="."><plain>On the other hand, positive expression of both HDAC-1 and MTA-1 was found in 6 out of 7 (85.7%) cases with Barrett's epithelium and 7 out of 7 (100%) cases with gastro-esophageal-junction-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Positive expression of HDAC-1 and MTA-1 was found even in low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, BE with HDAC-1 and MTA-1 expression is considered to be a precancerous lesion re quiring curative treatment </plain></SENT>
</text></document>